Mabion
  • Company
    • About us
      • History
      • Leaderships
      • Team
      • EU grants
      • Requests for Proposal
      • Sustainability – ESG
      • Bussines strategy
      • Quality policy
      • Virtual Tour
    • Investors
      • Corporate documents
      • Shareholders and shares
      • Periodic reports
      • Current reports
      • Sustainability reports
      • Corporate governance at Mabion
      • Financial data
      • For Investors
      • Calendar
  • Resources
    • Science Hub
    • Press releases
    • News
    • Events
    • Media kit
  • Services
    • Process Development
    • Analytics 
    • Drug Substance Manufacturing
  • Contact
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • Science News
  • Resources

Antibody-drug conjugates

ADC development

Challenges and Solutions in ADC Development for Biologic Therapeutics

Antibody-drug conjugates, Biologics, Drug development
ADC Manufacturing Services

ADC Manufacturing – A Comprehensive Guide to Drug Substance Manufacturing Services

Antibody-drug conjugates, GMP, Manufacturing
Scaling Antibody Production for ADC Programs in Mabion manufacturing zone

Scaling Antibody Production for ADC Programs

Antibody-drug conjugates, Drug development, Manufacturing
innovative biologics 2026

Innovative Biologics Expected Approvals in 2026

Antibody-drug conjugates, Biologics, Bispecific antibody, Clinical trials, EMA, FDA, Monoclonal antibody, Vaccines
antibody drug-conjugates development

Breaking Barriers in Antibody-Drug Conjugates Development

Antibody-drug conjugates, Cancer
Innovative biologics that are expected to be approved in 2025

Innovative Biologics – Expected Drug Approvals in 2025

Antibody-drug conjugates, Biologics, Bispecific antibody, Clinical trials, EMA, FDA, Monoclonal antibody, Vaccines

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • CDMO
    • Media kit
    • Press releases
    • Events

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. HTML Sitemap

    Powered by

    Veneo